| Literature DB >> 26121677 |
Brendan Collins1, Simon Capewell2, Martin O'Flaherty2, Hannah Timpson3, Abdul Razzaq4, Sylvia Cheater5, Robin Ireland5, Helen Bromley2.
Abstract
BACKGROUND: Increasing evidence associates excess refined sugar intakes with obesity, Type 2 diabetes and heart disease. Worryingly, the estimated volume of sugary drinks purchased in the UK has more than doubled between 1975 and 2007, from 510 ml to 1140 ml per person per week. We aimed to estimate the potential impact of a duty on sugar sweetened beverages (SSBs) at a local level in England, hypothesising that a duty could reduce obesity and related diseases. METHODS ANDEntities:
Mesh:
Substances:
Year: 2015 PMID: 26121677 PMCID: PMC4486083 DOI: 10.1371/journal.pone.0130770
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Schematic of SSB model for local authorities in England.
Fig 2Percentage of England population who are SSB consumers by age group and gender.
Data for England from NDNS 2008–10 [20].
Fig 3Average grams per day consumed of soft drinks by age group and gender (includes non-consumers of soft drinks).
Data for England from NDNS, 2008–10 [20].
Average consumption per day of SSBs and impact of a 20% duty on calories (low and high estimates), data by gender and age group, based on NDNS data for 2008–10 [20].
| Gender | Age group | Average g per day soft drinks from NDNS | Kcals per day soft drinks all (low estimate based on NDNS) | kcals per day increased by factor of 3.1 (478/156ml)based on manufacturer data (high estimate) | Example: Reduction in kcals per day from 20% duty resulting in 9.1% decrease in consumption | |
|---|---|---|---|---|---|---|
| Low estimate (NDNS) | High estimate (Manufacturer data) | |||||
| Male | 4–10 | 141 | 44 | 136 | 4.00 | 12.41 |
| Male | 11–18 | 314 | 98 | 304 | 8.92 | 27.64 |
| Male | 19–64 | 173 | 54 | 167 | 4.91 | 15.23 |
| Male | 65+ | 48 | 15 | 46 | 1.36 | 4.22 |
| Female | 4–10 | 127 | 40 | 123 | 3.61 | 11.18 |
| Female | 11–18 | 247 | 77 | 239 | 7.01 | 21.74 |
| Female | 19–64 | 110 | 34 | 106 | 3.12 | 9.68 |
| Female | 65+ | 52 | 16 | 50 | 1.48 | 4.58 |
Outcomes associated with obesity scenarios, from Wang et al.
Change in disease cases (incidence) and QALYs, 2010–2030, United Kingdom.
| Disease | Scenario 1 –Assuming recent trends continue | Scenario 2 Assuming 1% reduction in BMI for every adult at baseline—needs average net reduction of 20kcal per person per day | Scenario 3 if obesity rates had remained at 1990 levels |
|---|---|---|---|
| Change in Diabetes cases | +545,000 | -179,000 | -897,000 |
| Change in CHD and Stroke cases | +331,000 | -122,000 | -634,000 |
| Change in Cancer cases | +87,000 | -32,000 | -177,000 |
| QALYs gained or lost | -2,219,000 | +3,011,000 | +7,073,000 |
Annual cost of diseases used in model.
| Diabetes | CHD and Stroke | Cancer | |
|---|---|---|---|
| Average cost per year of treatment | £1371 | £4614 | £8808 |
| Details | Average healthcare cost of control group (usual treatment for type 2 diabetes). | Hospital cost of CVD event | Average cost per patient per year for bowel cancer |
| Source | Farmer (2009) [ | NICE (2010) [ | Trueman (2007) [ |
Fig 4Thematic map showing estimated kcal reduction per person per day by local authority as a result of a 20% SSB duty.
Fig 5Thematic map showing estimated QALYs gained per year by local authority as a result of a 20% SSB duty.
Results from Monte Carlo simulation model for England.
| Parameter | Probability distribution for simulation (Standard Deviation) | Mean (based on simulations) | 2.5% percentile—lowest impact scenario | 97.5% percentile—highest impact scenario |
|---|---|---|---|---|
| SSB Consumption (ml/person/day) | Normal (91) | 301 | 126 | 473 |
| Price Elasticity of Demand | Normal (-0.12) | -0.691 | -0.462 | -0.922 |
| Substitution of calories from SSBs with a 20% duty (kcal) | Normal (0.91) | 1.78 | 0.03 | 3.57 |
| Net impact—Calorie reduction per person per day | Calculated | 6.5 | 1.1 | 13 |
| Estimated change in diabetes cases/year | Calculated | -2432 | -412 | -4864 |
| Estimated change in Stroke/CHD cases/year | Calculated | -1657 | -280 | -3314 |
| Estimated change in Cancer cases/year | Calculated | -435 | -74 | -870 |
| Estimated QALYs gained /year | Calculated | 40,908 | 6,923 | 81,816 |
| Total health cost savings per year (£) | Calculated | 14,811,121 | 2,506,497 | 29,622,242 |